Allan Sniderman is a highly acclaimed Professor of Cardiology and Medicine at McGill University and a foremost expert in cardiovascular disease (CVD). In this episode, Allan explains the many risk factors used to predict atherosclerosis, including triglycerides, cholesterol, and lipoproteins, and he makes the case for apoB as a superior metric that is currently being underutilized. Allan expresses his frustration with the current scientific climate and its emphasis on consensus and unanimity over encouraging multiple viewpoints, thus holding back the advancement of metrics like apoB for assessing CVD risk, treatment, and prevention strategies. Finally, Allan illuminates his research that led to his 30-year causal model of risk and explains the potentially life-saving advantages of early intervention for the prevention of future disease.
We discuss:
A masterclass on insulin resistance—mechanisms and implications | Gerald Shulman, M.D., Ph.D. (#140 rebroadcast)
#231 - AMA #41: Medicine 3.0, developments in the field of aging, healthy habits in times of stress, and more
#230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more | Erin Michos, M.D.
#229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB
#228 ‒ Improving body composition, female-specific training principles, and overcoming an eating disorder | Holly Baxter, APD
#227 - AMA #40: Body composition, protein, time-restricted feeding, fasting, DEXA scans, and more
#226 ‒ The science of happiness | Arthur Brooks, Ph.D.
#225 ‒ The comfort crisis, doing hard things, rucking, and more | Michael Easter, MA
#224 ‒ Dietary protein: amount needed, ideal timing, quality, and more | Don Layman, Ph.D.
#223 - AMA #39: The Centenarian Decathlon, zone 2, VO2 max, and more
#222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D
#221 ‒ Understanding sleep and how to improve it
#220 ‒ Ketamine: Benefits, risks, and promising therapeutic potential | Celia Morgan, Ph.D.
#219 ‒ Dialectical behavior therapy (DBT): skills for overcoming depression , emotional dysregulation, and more | Shireen Rizvi, Ph.D., ABPP
#218 - AMA #38: Can you exercise too much?
#217 ‒ Exercise, VO2 max, and longevity | Mike Joyner, M.D.
#216 - Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.
#215 - The gut-brain connection | Michael Gershon, M.D.
#214 - AMA #37: Bone health—everything you need to know
#213 ‒ Liquid biopsies and cancer detection | Max Diehn, M.D. Ph.D.
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Huberman Lab
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.